Trading Report: The Deutsche Bank AG Reiterates Buy Rating for Aldermore Group PLC (ALD)

The Deutsche Bank AG Reiterates Buy Rating for Aldermore Group PLC (ALD)

Aldermore Group PLC (LON:ALD)‘s stock had its “buy” rating reiterated by research analysts at Deutsche Bank AG in a research report issued on Thursday. They presently have a GBX 194 ($2.42) target price on the stock. Deutsche Bank AG’s price target suggests a potential downside of 6.33% from the stock’s previous close.

ALD has been the subject of a number of other reports. Macquarie restated an “outperform” rating and set a GBX 245 ($3.06) price objective (up from GBX 240 ($3.00)) on shares of Aldermore Group PLC in a research report on Monday, November 14th. JPMorgan Chase & Co. restated a “neutral” rating and set a GBX 165 ($2.06) price objective on shares of Aldermore Group PLC in a research report on Friday, August 12th. Royal Bank Of Canada upped their price objective on shares of Aldermore Group PLC from GBX 175 ($2.19) to GBX 190 ($2.37) and gave the stock a “sector performer” rating in a research report on Friday, September 23rd. Credit Suisse Group AG cut shares of Aldermore Group PLC to a “neutral” rating and reduced their price objective for the stock from GBX 185 ($2.31) to GBX 180 ($2.25) in a research report on Tuesday, October 25th. Finally, BNP Paribas restated a “neutral” rating and set a GBX 165 ($2.06) price objective on shares of Aldermore Group PLC in a research report on Friday, August 12th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of GBX 215.45 ($2.69).

Aldermore Group PLC (LON:ALD) opened at 203.50 on Thursday. The company’s market capitalization is GBX 701.54 million. The firm has a 50-day moving average of GBX 184.34 and a 200 day moving average of GBX 170.03. Aldermore Group PLC has a 52-week low of GBX 102.00 and a 52-week high of GBX 243.02.

Related posts

Leave a Comment